v3.26.1
STOCKBASED COMPENSATION (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2026
May 31, 2026
Feb. 27, 2023
Jun. 28, 2026
Jun. 29, 2025
Jun. 28, 2026
Jun. 29, 2025
Dec. 31, 2023
Description of option granted           the Board granted 62,500 options with an exercise price of $1.50 per share. This grant included 22,500 fully-vested one-year options and 40,000 options that vest 20% upon grant and 20% on each of the succeeding four anniversary dates    
Description of consultant shares purchase           we issued 15,000 ten-year options to the then-existing outside member of our Board of Directors to purchase shares at $1.61 per share; we also granted 5,000 fully vested options to purchase shares at $1.70 per share to a new member of the Board. In 2022, we granted 216,000 options, including 175,000 to company officers and 41,000 to employees and a consultant, to purchase shares at $2.58 per share   we granted a consultant a warrant to purchase 100,000 shares at $2.50 per share, exercisable for seven years. The warrant vests monthly over five years
Descrition of consulting agreement           we project that approximately $80,000 in stock-based compensation will be recognized, with $32,000 recognized in each of the next two years and $16,000 recognized in 2028    
Stock options granted           0 0  
Stock based compensation       $ 43,084 $ 62,735 $ 59,459 $ 93,735  
Granted Options to purchase     250,000          
Purchase price per share     $ 8.50          
Shares forfeited   100,000            
Trading days     20          
2019 Plan                
Stock options granted 180,000              
Shares available for a grant           718,250    
Stock based compensatisation 2024                
Stock based compensation     $ 265,000          
Employees And Director [Member]                
Descrition of annual installments agreement           Stock-based compensation expense, equal to the fair value of the options at the grant date, is recognized in general and administrative expense over the applicable service period. Total stock-based compensation expenses for stock options and warrants for the 26-week periods in 2026 and 2025 were $59,459 and $93,735, respectively. As of June 28, 2026, we estimated that approximately $191,000 in stock-based compensation expense for stock options, including consultant warrants, would be recognized over the next four years: $54,000 in 2026, and $58,000 in 2027, $40,000 in 2028, $26,000 in 2029, and $14,000 in 2030